|
|
|
Volumn 22, Issue 12, 2013, Pages 42-43
|
|
Ponatinib pulled off market over safety issues
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
IMIDAZOLE DERIVATIVE;
PONATINIB;
PYRIDAZINE DERIVATIVE;
DRUG RECALL;
HUMAN;
NOTE;
UNITED STATES;
ANTINEOPLASTIC AGENTS;
HUMANS;
IMIDAZOLES;
PYRIDAZINES;
SAFETY-BASED DRUG WITHDRAWALS;
UNITED STATES;
|
|
EID: 84893983057
PISSN: 10623388
EISSN: None
Source Type: Trade Journal
DOI: None Document Type: Note |
|
Times cited : (11)
|
|
References (0)
|
